logo

For the Inventor, By the Inventor

Bedford, MA, United States of America

Stoke Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 10


Trademarks = 1

Forward Citations = 16

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Isabel Aznarez (10 out of 14 patents)

silverMedal Zhou Han (3 out of 3 patents)

bronzeMedal Gene Liau (3 out of 3 patents)

4.  Aditya Venkatesh (3 out of 3 patents)

5.  Huw M Nash (2 out of 35 patents)

6.  Adrian R Krainer (2 out of 14 patents)

7.  Enxuan Jing (5 patents)

8.  Baruch Ticho (0 patent)

9.  Juergen Scharner (0 patent)

10.  Jacob Kach (0 patent)

11.  Adrian Krainer (0 patent)

12.  Adrian Krainer (0 patent)


10 patents:

1. 12753408 - OPA1 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES (2026-10-06),
2. 12577561 - ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES (2026-03-17),
3. 12338437 - OPA1 antisense oligomers for treatment of conditions and diseases (2025-06-24),
4. 12060558 - Methods and compositions for treatment of cholesteryl ester storage disease (2024-08-13),
5. 11873490 - Antisense oligomers for treatment of conditions and diseases (2024-01-16),
6. 11814622 - OPA1 antisense oligomers for treatment of conditions and diseases (2023-11-14),
7. 11096956 - Antisense oligomers and uses thereof (2021-08-24),
8. 11083745 - Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome (2021-08-10),
9. 10913947 - Antisense oligomers for treatment of conditions and diseases (2021-02-09),
10. 10683503 - Antisense oligomers for treatment of conditions and diseases (2020-06-16),
Company Overview
Stoke Therapeutics, Inc. is a biotechnology company based in Bedford, MA, focused on developing innovative therapies for genetic diseases. The company specializes in RNA-based approaches to enhance protein expression, aiming to address the underlying causes of various disorders. By leveraging its proprietary technology platform, Stoke seeks to create transformative treatments that can significantly improve patient outcomes in areas of high unmet medical need, particularly in the field of neurology and other genetic conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

10 Patents

#54 in Bedford, MA

#1,779 in Massachusetts

#29,944 in US

#56,228 in the World

Bedford, MA (US)
Bedford, MA, United States of America

Stoke Therapeutics, Inc.

Forward Citations = 16

6 inventors:

goldMedal Isabel Aznarez (10 out of 14 patents)

silverMedal Zhou Han (3 out of 3 patents)

bronzeMedal Gene Liau (3 out of 3 patents)

4.  Aditya Venkatesh (3 out of 3 patents)

5.  Huw M Nash (2 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Stoke Therapeutics, Inc.. Retrieved from https://idiyas.com/company/stoke-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…